NASDAQ:GBS
Delisted
GBS Inc. Stock News
$0.81
-0.111 (-12.05%)
At Close: Jan 27, 2023
GBS Inc.: Pioneering Non-Invasive, Real-Time Diagnostic Testing
01:09am, Monday, 09'th Aug 2021
GBS Inc.: Pioneering Non-Invasive, Real-Time Diagnostic Testing
GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology
09:21am, Thursday, 08'th Jul 2021
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at poin
Hot Penny Stocks to Buy Under $5? 3 You Might Not Have Heard Of
02:54pm, Saturday, 12'th Jun 2021
Looking for penny stocks under $5? Check these 3 out The post Hot Penny Stocks to Buy Under $5?
GBS Stock Price: Over 45% Increase Pre-Market Explanation
07:53am, Friday, 11'th Jun 2021
The stock price of GBS Inc (NASDAQ: GBS) increased by over 45% pre-market. These are the details.
Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick' Alternative in Global Glucose Monitoring Survey
08:10am, Tuesday, 08'th Jun 2021
Global results show 90% of patients are in favor of a saliva-based glucose test Global results show 90% of patients are in favor of a saliva-based glucose test
GBS Inc. Reports First Quarter 2021 Financial Results and Recent Business Highlights
08:30am, Friday, 14'th May 2021
- Anticipate Emergency Use Submission for SARS-CoV-2 Antibody Biosensor Test in the Second Half of 2021-
GBS, Inc. Receives Approval to Commence Validation Clinical Study for Rapid SARS-CoV-2 Diagnostic Test
11:29am, Thursday, 15'th Apr 2021
NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- GBS, Inc. (NasdaqGS: GBS), a life sciences company developing non-invasive, real-time point-of-care (POC) diagnostic tests, and the Wyss Institute for Biol
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company that develops non-invasive, real-time point of care (POC) diagnostic tests for patients and their primary he
GBS, Inc. Announces Closing of Upsized $21.6 Million Initial Public Offering
05:13pm, Monday, 28'th Dec 2020
NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (the “Company”) (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their
UPDATE - GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering
10:49am, Wednesday, 23'rd Dec 2020
Will Trade on the Nasdaq Global Market Under Ticker “GBS” Will Trade on the Nasdaq Global Market Under Ticker “GBS”
